Gyre Therapeutics, Inc. Preferred Stock, Par or Stated Value Per Share
Gyre Therapeutics, Inc. (GYRE) had Preferred Stock, Par or Stated Value Per Share of $0.00 per share as of 2023-12-31, per its 10-K filed 2024-03-27.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2024-03-27
- 2023-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2023-09-30: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2023-06-30: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2022-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
| Period end | Preferred Stock, Par or Stated Value Per Share |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-27 |
| 2023-09-30 | $0.00 10-Q · filed 2023-10-26 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-30 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-14 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-04 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-20 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-03 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-08 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-11 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-19 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-04 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-08 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 |
| 2015-06-30 | $0.00 10-Q · filed 2015-07-31 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-09 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-08 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-06 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-07 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-14 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-09 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-09 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-15 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-03 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |